GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgene SA (XPAR:TNG) » Definitions » Other Current Receivables

Transgene (XPAR:TNG) Other Current Receivables : €0.13 Mil (As of Dec. 2023)


View and export this data going back to 1998. Start your Free Trial

What is Transgene Other Current Receivables?

Transgene's Other Current Receivables for the quarter that ended in Dec. 2023 was €0.13 Mil.

Transgene's quarterly Other Current Receivables increased from Dec. 2022 (€0.15 Mil) to Jun. 2023 (€14.33 Mil) but then stayed the same from Jun. 2023 (€14.33 Mil) to Dec. 2023 (€0.13 Mil).

Transgene's annual Other Current Receivables declined from Dec. 2021 (€0.26 Mil) to Dec. 2022 (€0.15 Mil) and declined from Dec. 2022 (€0.15 Mil) to Dec. 2023 (€0.13 Mil).


Transgene Other Current Receivables Historical Data

The historical data trend for Transgene's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgene Other Current Receivables Chart

Transgene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.21 0.26 0.15 0.13

Transgene Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.28 0.15 14.33 0.13

Transgene Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Transgene Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Transgene's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Transgene (XPAR:TNG) Business Description

Industry
Traded in Other Exchanges
Address
400 Boulevard Gonthier d’Andernach, Parc d’Innovation - CS80166, Illkirch-Graffenstaden, FRA, 67400
Transgene SA is a biotechnology company. It is involved in the business of discovering and focusing immune-targeted therapies for the treatment of cancer and infectious diseases. The company's clinical-stage programs are TG4010 for non-small cell lung cancer and Pexa-vec for liver cancer. Its product pipeline includes TG4001, TG1050, TG6002 etc. It is engaged in clinical research and development of therapeutic vaccines and immunotherapeutic products.

Transgene (XPAR:TNG) Headlines

No Headlines